Thomas J. Polascik, MD

Articles by Thomas J. Polascik, MD

Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright

May 14th 2021

Thomas J. Polascik, MD, reflects on a manuscript written by his colleagues regarding the use of focal therapy to treat localized prostate cancer.

Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other

ByLaurence Klotz, MD, FRCSC, CM,Thomas J. Polascik, MD

November 15th 2014

Investigators and physicians caring for the spectrum of prostate cancer should have a targeted treatment option available for patients who would benefit by it.

Thomas J. Polascik, MD

Articles by Thomas J. Polascik, MD

Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright

Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers

Bevacizumab Biosimilar Shows Clinical Equivalence in Advanced NSCLC

Nadofaragene Firadenovec Label Update Approved in BCG-Unresponsive NMIBC

IMNN-001 Plus Neoadjuvant Chemo Improves OS in Advanced Ovarian Cancer

When To Consider a Re-Biopsy in the Metastatic CRPC Treatment Course